ULVR · story · 3 October – 6 October
Unilever · 3 headlines from 3 outlets, from 3 October 2026 to 6 October 2026.
Reports cover Unilever's €1.243bn Dr. Squatch purchase and Sundial Brands acquisition.
The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.
Campaign UK is the largest at 5.8, ahead of Fast Company (5.0). OpenPR.com is the smallest at 4.2.
Source: MarketFrame news analysis
| outlet | Average tone |
|---|---|
| Campaign UK | 5.8 |
| Fast Company | 5.0 |
| openPR.com | 4.2 |
| Outlet | Headlines | Average tone |
|---|---|---|
| Campaign UK | 1 | +5.8 |
| Fast Company | 1 | +5.0 |
| openPR.com | 1 | +4.2 |
One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.
| Tone | What the article reported, and why it scored that way |
|---|---|
| +5.0 | Explains why Unilever bought Dr. Squatch and Grüns within its growth strategy. |
| Tone | What the article reported, and why it scored that way |
|---|---|
| +5.8 | Acquisition of Sundial Brands supports beauty portfolio |
| +4.2 | Dr. Squatch acquisition strengthens men's personal care position |
A short, free morning email on how the news treated Unilever: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.